Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP75135.RAgVdexk_k8X2LeeNiQ6H8kb7IYk2m__7RrPyzEkhlSwA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP75135.RAgVdexk_k8X2LeeNiQ6H8kb7IYk2m__7RrPyzEkhlSwA130_assertion type Assertion NP75135.RAgVdexk_k8X2LeeNiQ6H8kb7IYk2m__7RrPyzEkhlSwA130_head.
- NP75135.RAgVdexk_k8X2LeeNiQ6H8kb7IYk2m__7RrPyzEkhlSwA130_assertion description "[Genomic DNA was isolated from 214 CTEPH subjects and 200 healthy controls, and analysed for Factor V Leiden, prothrombin guanine (G) to adenine (A) substitution at nucleotide 20210 (20210G>A), plasminogen activator inhibitor-1 4G/5G, tissue plasminogen activator 7351 cytosine (C)>thymidine (T), Factor XIII 100G>T, fibrinogen Aalpha substitution of threonine with alanine at position 312 (Thr312Ala), fibrinogen Bbeta substitution of arginine with lysine at position 448 (Arg448Lys) and fibrinogen Bbeta 455G>A polymorphisms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP75135.RAgVdexk_k8X2LeeNiQ6H8kb7IYk2m__7RrPyzEkhlSwA130_provenance.
- NP75135.RAgVdexk_k8X2LeeNiQ6H8kb7IYk2m__7RrPyzEkhlSwA130_assertion evidence source_evidence_literature NP75135.RAgVdexk_k8X2LeeNiQ6H8kb7IYk2m__7RrPyzEkhlSwA130_provenance.
- NP75135.RAgVdexk_k8X2LeeNiQ6H8kb7IYk2m__7RrPyzEkhlSwA130_assertion SIO_000772 18057060 NP75135.RAgVdexk_k8X2LeeNiQ6H8kb7IYk2m__7RrPyzEkhlSwA130_provenance.
- NP75135.RAgVdexk_k8X2LeeNiQ6H8kb7IYk2m__7RrPyzEkhlSwA130_assertion wasDerivedFrom gad-20130706 NP75135.RAgVdexk_k8X2LeeNiQ6H8kb7IYk2m__7RrPyzEkhlSwA130_provenance.
- NP75135.RAgVdexk_k8X2LeeNiQ6H8kb7IYk2m__7RrPyzEkhlSwA130_assertion wasGeneratedBy ECO_0000203 NP75135.RAgVdexk_k8X2LeeNiQ6H8kb7IYk2m__7RrPyzEkhlSwA130_provenance.